Spotlight On Sjogren’s Disease
Sjögren’s disease presents a unique clinical challenge as it’s often underdiagnosed and frequently misunderstood. That’s why our Spotlight On Sjögren’s Disease series is designed for rheumatologists, primary care providers, and other specialists encountering patients with systemic symptoms who are looking for the latest insights into the pathophysiology, diagnosis, and management of this complex autoimmune condition.
16-23 of 23
Detecting Sjögren’s Disease Early: Why Education and Awareness Matters
Living RheumDetecting Sjögren’s Disease Early: Why Education and Awareness Matters
Nancy Carteron, MD
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Living RheumDifferentiating and Diagnosing Sjögren’s-Related Dry Eye
Michelle Hessen, OD
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Living RheumSjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Michelle Hessen, OD
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Living RheumEpithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Ryan Quigley
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Living RheumAssessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Marlene Mimi Maeusli, PhD.
Reframing Sjögren’s Syndrome: Insights from a Comprehensive Review
Living RheumReframing Sjögren’s Syndrome: Insights from a Comprehensive Review
- advertisement
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Living RheumEfgartigimod Shows Early Promise for Primary Sjögren’s Disease
Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Living RheumUnmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care